Event: Pharmaceutical IP Licensing Asia
Dates: November 23 and 24, 2009
Venue: TBD, Singapore
Contact: Devashini Satiananden
Email: devashini.s@informa.com
Tel: +65 6835 5131

As more blockbuster drugs go off-patent with few innovative options in pipelines, the role of licensing has been brought to the forefront. There are many options of how companies can work together with potential partners and collaborators, in order to achieve strategic corporate objectives in different key markets.

This increase in activity as well as growing complexity of licensing agreements makes it imperative for pharmaceutical industry stakeholders such as you to scrutinise and fully understand your rights and obligations in licensing contracts.

As an extension of its pharmaceutical series of events, IBC Life Sciences Asia brings you Pharmaceutical IP Licensing Asia. This event is planned as one of the first of its kind in Asia, focusing on the legal and business aspects of IP commercialisation in the pharmaceutical industry.

Featuring a unique program structure for maximising learning, Pharmaceutical IP Licensing Asia is the event not-to-missed for all those keen in gaining up-to-the-minute understanding on the legal considerations of pharmaceutical licensing in Asia and how they can best protect their IP rights in these markets.

For full program details and speaking opportunities , please contact Devashini Satiananden, via email devashini.s@informa.com or call: +65 6835 5131